We believe Veeda is well-positioned to capitalise on this opportunity as one of the largest independent full-service clinical research organisations, Sabres founder and managing partner Rajiv Maliwal said.The Ahmedabad-headquartered Sabre has invested USD 280 million in its nearly two-decade existence and returned USD 1.7 billion to investors from its three funds.
IPO-bound Veeda Clinical Research raises $16 mln in round led by Sabre PE business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.